Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial

被引:167
作者
Masson, Serge [1 ]
Caironi, Pietro [2 ,3 ]
Spanuth, Eberhard [4 ]
Thomae, Ralf [5 ]
Panigada, Mauro [3 ]
Sangiorgi, Gabriela [6 ]
Fumagalli, Roberto [7 ]
Mauri, Tommaso [8 ,9 ]
Isgro, Stefano [7 ]
Fanizza, Caterina
Romero, Marilena
Tognoni, Gianni [10 ]
Latini, Roberto [1 ]
Gattinoni, Luciano [2 ,3 ]
机构
[1] IRCCS Ist Ric Farmacol Mario Negri, I-20156 Milan, Italy
[2] Univ Milan, Dipartimento Fisiopatol Med Chirurg & Trapianti, Fdn IRCCS Ca Granda Osped Maggiore Policlin, I-20122 Milan, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dipartimento Anestesia Rianimaz & Terapia Dolore, I-20122 Milan, Italy
[4] Diagnost Engn & Res GmbH, D-69221 Heidelberg, Germany
[5] Mitsubishi Chem Europe GmbH, D-40549 Dusseldorf, Germany
[6] Policlin Univ S Orsola Malpighi, Dipartimento Emergenza Urgenza Chirurgia Gen & Tr, I-40138 Bologna, Italy
[7] AO San Gerardo, UO Anestesia Rianimaz, I-20900 Monza, Italy
[8] Osped San Gerardo, Dipartimento Emergenza, I-20900 Monza, Italy
[9] Milano Bicocca Univ, I-20900 Monza, Italy
[10] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy
关键词
INTERNATIONAL GUIDELINES; HYDROXYETHYL STARCH; FLUID RESUSCITATION; PROGNOSTIC VALUE; SEPTIC SHOCK; MANAGEMENT; THERAPY; BIOMARKERS; DIAGNOSIS; CAMPAIGN;
D O I
10.1186/cc13183
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Sepsis, a leading cause of death in critically ill patients, is the result of complex interactions between the infecting microorganisms and the host responses that influence clinical outcomes. We evaluated the prognostic value of presepsin (sCD14-ST), a novel biomarker of bacterial infection, and compared it with procalcitonin (PCT). Methods: This is a retrospective, case-control study of a multicenter, randomized clinical trial enrolling patients with severe sepsis or septic shock in ICUs in Italy. We selected 50 survivors and 50 non-survivors at ICU discharge, matched for age, sex and time from sepsis diagnosis to enrollment. Plasma samples were collected 1, 2 and 7 days after enrollment to assay presepsin and PCT. Outcome was assessed 28 and 90 days after enrollment. Results: Early presepsin (day 1) was higher in decedents (2,269 pg/ml, median (Q1 to Q3), 1,171 to 4,300 pg/ml) than in survivors (1,184 pg/ml (median, 875 to 2,113); P = 0.002), whereas PCT was not different (18.5 mu g/L (median 3.4 to 45.2) and 10.8 mu g/L (2.7 to 41.9); P = 0.31). The evolution of presepsin levels over time was significantly different in survivors compared to decedents (P for time-survival interaction = 0.03), whereas PCT decreased similarly in the two groups (P = 0.13). Presepsin was the only variable independently associated with ICU and 28-day mortality in Cox models adjusted for clinical characteristics. It showed better prognostic accuracy than PCT in the range of Sequential Organ Failure Assessment score (area under the curve (AUC) from 0.64 to 0.75 vs. AUC 0.53 to 0.65). Conclusions: In this multicenter clinical trial, we provide the first evidence that presepsin measurements may have useful prognostic information for patients with severe sepsis or septic shock. These preliminary findings suggest that presepsin may be of clinical importance for early risk stratification.
引用
收藏
页数:9
相关论文
共 26 条
[1]   Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome [J].
Charles, Pierre Emmanuel ;
Tinel, Claire ;
Barbar, Saber ;
Aho, Serge ;
Prin, Sebastien ;
Doise, Jean Marc ;
Olsson, Nils Olivier ;
Blettery, Bernard ;
Quenot, Jean Pierre .
CRITICAL CARE, 2009, 13 (02)
[2]   Diagnostic and prognostic value of procalcitonin in patients with septic shock [J].
Clec'h, C ;
Ferriere, F ;
Karoubi, P ;
Fosse, JP ;
Cupa, M ;
Hoang, P ;
Cohen, Y .
CRITICAL CARE MEDICINE, 2004, 32 (05) :1166-1169
[3]  
Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]
[4]  
Dellinger RP, 2008, INTENS CARE MED, V34, P783, DOI [10.1007/s00134-007-0934-2, 10.1007/s00134-008-1040-9, 10.1097/01.CCM.0000298158.12101.41]
[5]   Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study [J].
Endo, Shigeatsu ;
Suzuki, Yasushi ;
Takahashi, Gaku ;
Shozushima, Tatsuyori ;
Ishikura, Hiroyasu ;
Murai, Akira ;
Nishida, Takeshi ;
Irie, Yuhei ;
Miura, Masanao ;
Iguchi, Hironobu ;
Fukui, Yasuo ;
Tanaka, Kimiaki ;
Nojima, Tsuyoshi ;
Okamura, Yoshikazu .
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (06) :891-897
[6]  
Faix JD, 2011, BIOMARK MED, V5, P117, DOI [10.2217/BMM.11.21, 10.2217/bmm.11.21]
[7]  
Finfer S, 2004, NEW ENGL J MED, V350, P2247
[8]   Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis [J].
Gibot, S ;
Cravoisy, A ;
Kolopp-Sarda, MN ;
Béné, MC ;
Faure, G ;
Bollaert, PE ;
Levy, B .
CRITICAL CARE MEDICINE, 2005, 33 (04) :792-796
[9]   Procalcitonin increase in early identification of critically ill patients at high risk of mortality [J].
Jensen, Jens Ulrik ;
Heslet, Lars ;
Jensen, Tom Hartvig ;
Espersen, Kurt ;
Steffensen, Peter ;
Tvede, Michael .
CRITICAL CARE MEDICINE, 2006, 34 (10) :2596-2602
[10]   Diagnostic and prognostic biomarkers of sepsis in critical care [J].
Kibe, Savitri ;
Adams, Kate ;
Barlow, Gavin .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 :II33-II40